Understanding human papillomavirus vaccination intentions: Comparative utility of the theory of reasoned action and the theory of planned behavior in vaccine target age women and men

Journal of Sexual Medicine

Volumn 10, Issue 10, 2013, Pages 2455-2464

  Fisher, William A ^a   Kohut, Taylor ^a   Salisbury, Claire M A ^a   Salvadori, Marina I ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

HPV Vaccine; Human Papillomavirus; Theory of Planned Behavior; Theory of Reasoned Action

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; ATTITUDE; FEMALE; HEALTH BEHAVIOR; HEALTH EDUCATION; HUMAN; HUMAN PAPILLOMAVIRUS VACCINATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; PERCEPTION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; SOCIAL SUPPORT; THEORY OF PLANNED BEHAVIOR; THEORY OF REASONED ACTION; VACCINATION;

HPV VACCINE; HUMAN PAPILLOMAVIRUS; THEORY OF PLANNED BEHAVIOR; THEORY OF REASONED ACTION;

ADOLESCENT; ADULT; CANADA; CULTURE; FEMALE; HEALTH BEHAVIOR; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTENTION; MALE; MODELS, PSYCHOLOGICAL; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PERCEPTION; QUESTIONNAIRES; SEX FACTORS; SOCIAL SUPPORT; VACCINATION; YOUNG ADULT;

EID: 84885904246     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12211     Document Type: Article

References (53)

1. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-819.
2. Giuliano AR, Lee JH, Fulp W, Villa LL, Lazcano E, Papenfuss MR, Abrahamsen M, Salmeron J, Anic GM, Rollison DE, Smith D. Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study. Lancet 2011;377:932-940.
3. Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, Coutlée F, Franco EL. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003;12:485-490.
4. Sellors JW, Mahony JB, etal. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. CMAJ 2000;163:503-508.
5. Winer RL, Feng Q, Hughes JP, O'Reilly S, Kiviat NB, Koutsky LA. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis 2008;197:279-282.
6. Campion MJ, Brown JR, McCance DJ, Atia W, Edwards R, Cuzick J, Singer A. Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol 1988;95:175-181.
7. Chaturvedi AK. Beyond cervical cancer: Burden of other HPV-related cancers among men and women. J Adolesc Health 2010;46:S20-26.
8. Drolet M, Brisson M, Maunsell E, Franco EL, Coutlee F, Ferenczy E, Ratnam S, Fisher W, Mansi JA. The impact of anogenital warts on health-related quality of life: A 6-month prospective study. Sex Transm Dis 2011;38:949-956.
9. Drolet M, Brisson M, Maunsell E, Franco EL, Coutlee F, Ferenczy A, Fisher W, Mansi JA. The psychosocial impact of an abnormal cervical smear result. Psychooncology 2012;21:1071-1081.
10. Daley EM, Perrin KM, McDermott RJ, Vamos CA, Rayko HL, Packing-Ebuen JL. The psychosocial burden of HPV: A mixed-method study of knowledge, attitudes and behaviors among HPV positive women. J Health Psychol 2010;15:279-290.
11. Filberti A, Tamburin M, Stefanon B, Merola M, Bandieramonte G, Ventafridda V, De Palo G. Psychological aspects of genital human papillomavirus infection: A preliminary report. J Psychosom Obstet Gynaecol 1993;14:143-152.
12. Palefsky JM. Human papillomavirus-related disease in men: Not just a women's issue. J Adolesc Health 2010;46(suppl 4):S12-19.
13. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006;24(suppl 3):S11-25.
14. Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, Ehlen T, Dobson S, Money D, Patrick DM, Naus M. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: Parental factors associated with HPV vaccine receipt. PLoS Med 2010;7:1-11.
15. Fisher WA. Understanding human papillomavirus vaccine uptake. Vaccine 2012;30(S5):F149-156.
16. Fishbein M, Ajzen I. Belief, attitude, intention, and behavior: An introduction to theory and research. Reading, MA: Addison-Wesley; 1975.
17. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991;50:179-211.
18. Centers for Disease Control and Prevention. Genital HPV infection fact sheet [Internet]. Atlanta, GA: Centers for Disease Control and Prevention; Available at: http://www.cdc.gov/std/HPV/STDFact-HPV.htm (updated 2012 Feb 15; accessed March 14, 2012).
19. Koshiol JE, Schroeder JC, Jamieson DJ, Marshall SW, Duerr A, Heilig CM, Shah KV, Klein RS, Cu-Uvin S, Schuman P, Celentano D, Smith JS. Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer 2006;119:1623-1629.
20. Fleurence RL, Dixon JM, Milanova TF, Beusterien KM. Review of the economic and quality-of-life burden of cervical human papillomavirus disease. Am J Obstet Gynecol 2007;196:206-212.
21. Graziottin A, Serafini A. HPV infections in women: Psychosexual impact of genital warts and intraepithelial lesions. J Sex Med 2009;6:633-645.
22. Sadeghi-Nejad H, Wasserman M, Weidner W, Richardson D, Goldmeier D. Sexually transmitted dieseases and sexual function. J Sex Med 2010;7:389-413.
23. Mast TC, Zhu X, Demuro-Mercon C, Cummings HW, Sings HL, Ferris DG. Development and psychometric properties of the HIV Impact Profile (HIP) to assess the psychosocial burden of HPV. Curr Med Res Opin 2009;25:2609-2619.
24. McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, Wardle A. Testing positive for human papillomavirus in routine cervical screening: Examination of psychosocial impact. BJOG 2004;111:1437-1443.
25. Linnehan MJ, Groce E. Counseling and educational interventions for women with genital human papillomavirus infection. AIDS Patient Care STDS 2000;14:439-445.
26. Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Holmes KL, Koutsky LA. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006;354:2645-2654.
27. Bearinger LH, Sieving RE, Duke NN, McMorris BJ, Stoddard SA, Pettingell SL. Adolescent condom use consistency over time: Global versus partner-specific measures. Nurs Res 2011;60(suppl 3):S68-78.
28. Black A, Yang Q, Wen SW, Lalonde AB, Guilbert E, Fisher WA. Contraceptive use among Canadian women of reproductive age: Results of a national survey. J Obstet Gynaecol Can 2009;31:627-640.
29. Misovich SJ, Fisher JD, Fisher WA. Close relationships and elevated HIV risk behavior: Evidence and possible underlying psychological processes. Rev Gen Psychol 1997;1:72-107.
30. Dobson S, Deeks S, Money D. Statement on human papillomavirus vaccine. Can Commun Dis Rep 2007;33:2-32. [Internet]. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07vol33/acs-02/index-eng.php (updated 2007 Feb 20; accessed March 12, 2012).
31. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine. MMWR Recomm Rep 2007;56:1-24. [Internet]. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm?s_cid=rr5602a1_e (accessed March 14, 2012).
32. Dawar M, Harris T, McNeil S. Update on human papillomavirus (HPV) vaccines. Can Commun Dis Rep 2012;38:1-62. [Internet]. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/12vol38/acs-dcc-1/index-eng.php (updated 2012 Jan 20; accessed March 14, 2012).
33. Dunne EF, Markowitz LE, Chesson H, Curtis CR, Sarayia M, Gee J, Unger ER. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60:1705-1708. [Internet]. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6050a3.htm (accessed March 14, 2012).
34. Liddon NC, Leichliter JS, Markowitz LE. Humpan papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med 2012;42:44-52.
35. Shearer BD. HPV vaccination: Understanding the impact on HPV disease. Purple Paper [Internet]. 2011 Dec;(34):1-18. December 2011. Available at: http://www.nccid.ca/files/Purple_Paper_Note_mauve/PP_34_EN.pdf (accessed January 31, 2013).
36. Dempsey A, Cohn L, Dalton V, Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine 2010;28:989-995.
37. Neubrand TPL, Breitkopf CR, Rupp R, Breitkopf D, Rosenthal SL. Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr (Phila) 2009;48:966-969.
38. Cook RL, Zhang J, Mullins J, Kauf T, Brumback B, Steingraber H, Mallison C. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health 2010;47:596-599.
39. Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics 2011;127:77-84.
40. Schluterman NH, Terplan M, Lydecker AD, Tracy JK. Human Papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine 2011;29:3767-3772.
41. Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, Kitchener H, McCann R. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: Prospective cohort study. BMJ 2012;335:1056-1058.
42. Rosenthal SL, Zimet GD. Adolescent males and human papillomavirus: Psychosexual development, infection, and vaccination. J Adolesc Health 2010;46(suppl 4):S1-2.
43. Daley EM, Marhefka SL, Buhi ER, Vamos CA, Hernandez ND, Giuliano AR. Humanpapillomavirus vaccine intentions among men participating in a human papillomavirus natural history study versus a comparison sample. Sex Transm Dis 2010;37:644-652.
44. Wheldon CW, Daleu EM, Buhi ER, Nyitray AG, Giulianob AR. Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the southeastern United States. Vaccine 2011;29:8060-8065.
45. Fisher JD, Fisher WA. Theoretical approaches to individual-level change in HIV risk behavior. In: Peteson J, DiClemente R, eds. Handbook of HIV prevention. New York: Plennum; 2000:3-55.
46. Sheppard BH, Hartwick J, Warshaw PR. The Theory of Reasoned Action: A meta-analysis of past research with recommendations for modifications and future research. J Consum Res 1988;15:325-343.
47. Armitage CJ, Conner M. Efficacy of the Theory of Planned Behaviour: A meta-analytic review. Br J Soc Psychol 2002;40:471-499.
48. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice-Hall; 1980.
49. Ajzen I, Madden TJ. Prediction of goal-directed behavior: Attitudes, intentions, and perceived behavioral control. J Exp Soc Psychol 1986;22:453-474.
50. Gagné C, Godin G. Does the easy-difficult item measure attitude or perceived behavioural control? Br J Health Psychol 2007;12:543-557.
51. Freeman GH, Halton JH. Note on exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 1951;38:141-149.
52. SPSS. Version 16.0. Chicago: SPSS Inc; 2007.
53. Webb TL, Sheeran P. Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence. Psychol Bull 2006;132:249-268.